Elaine Mardis

Elaine R. Mardis, PhD, the Robert E. and Louise F. Dunn Distinguished Professor of Medicine at the School of Medicine, has been named editor-in-chief of the journal Molecular Case Studies.

Elaine Mardis, PhD, the Robert E. and Louise F. Dunn Distinguished Professor of Medicine, has been elected to the board of directors of the American Association for Cancer Research (AACR).

Elaine R. Mardis, PhD, and Richard K. Wilson, PhD, both renowned for discoveries in the field of genomics, have been named to endowed professorships. They were installed by Chancellor Mark S. Wrighton (far left), and Larry J. Shapiro, MD, executive vice chancellor for medical affairs and dean of the School of Medicine (far right).

Elaine Mardis, co-director of The Genome Institute at Washington University School of Medicine in St. Louis, is featured in Discover magazine’s “100 Top Stories of 2013,” for her pioneering work in cancer genomics.

Scientists at the School of Medicine have identified a biological marker that may help predict overall survival of people with deadly brain tumors. The marker is made by noncancerous cells known as monocytes (pictured in brown).

Richard Wilson, PhD, director of The Genome Institute at Washington University School of Medicine, was named the world’s most-cited researcher by Thomson Reuters’ ScienceWatch. The list of most influential researchers also included Elaine Mardis, PhD, Li Ding, PhD, and Robert Fulton, all of The Genome Institute.

The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women. The new research is published in the journal Nature. Pictured are endometrial cancer cells under a microscope.